Before effective treatments were introduced in the 1950s, tuberculosis was a leading cause of death and disability in the United States. Health care workers were at particular risk. Although the occupational risk of tuberculosis has been declining in recent years, this new book from the Institute of Medicine concludes that vigilance in tuberculosis control is still needed in workplaces and communities. Tuberculosis in the Workplace reviews evidence about the effectiveness of control measuresa "such as those recommended by the Centers for Disease Control and Preventiona "intended to prevent transmission of tuberculosis in health care and other workplaces. It discusses whether proposed regulations from the Occupational Safety and Health Administration would likely increase or sustain compliance with effective control measures and would allow adequate flexibility to adapt measures to the degree of risk facing workers.
Marilyn J. Field, Editor, Committee on Regulating Occupational Exposure to Tuberculosis, Division of Health Promotion and Disease Prevention
1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 Basics of Tuberculosis; 5 3 Occupational Safety and Health Regulation in Context; 6 4 Comparison of CDC Guidelines and Proposed OSHA Rule; 7 5 Occupational Risk of Tuberculosis; 8 6 Implementation and Effects of CDC Guidelines; 9 7 Regulation and the Future of Tuberculosis in the Workplace; 10 References; 11 Appendix A Study Origins and Activities; 12 Appendix B The Tuberculin Skin Test; 13 Appendix C The Occupational Tuberculosis Risk of Health Care Workers; 14 Appendix D Effects of CDC Guidelines on Tuberculosis Control in Health Care Facilities; 15 Appendix E OSHA in a Health Care Context; 16 Appendix F Respiratory Protection and Control of Tuberculosis in Health Care and Other Facilities; 17 Appendix G Recommendations of the Institute of Medicine Committee; 18 Appendix H Committee Biographies; 19 Index
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, Committee on Postmarket Surveillance of Pediatric Medical Devices, Hugh Tilson, Marilyn J. Field
Institute of Medicine, Division of Health Care Services, Committee on Medicare Coverage Extensions, Lee Zwanziger, Robert L. Lawrence, Marilyn J. Field
Institute of Medicine, Board on Health Sciences Policy, Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA), Thomas F. Boat, Marilyn J. Field
Institute of Medicine, Board on Health Sciences Policy, Committee on Accelerating Rare Diseases Research and Orphan Product Development, Thomas F. Boat, Marilyn J. Field